Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,900 | -16,235 | -21,436 | -20,027 | -15,788 |
| Depreciation Amortization | N/A | 1 | 7 | 7 | 10 |
| Other Working Capital | -1,072 | -804 | 2,541 | -363 | -1,118 |
| Other Operating Activity | 4,793 | 1,146 | 2,479 | 3,400 | 4,470 |
| Operating Cash Flow | $-10,179 | $-15,892 | $-16,409 | $-16,983 | $-12,426 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | N/A | N/A | N/A | -400 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-400 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,379 | 3,583 | 5,925 | 13,701 | 31,465 |
| Financing Cash Flow | $15,379 | $3,583 | $5,925 | $13,701 | $31,465 |
| Beginning Cash Position | 3,053 | 15,362 | 25,846 | 29,128 | 10,489 |
| End Cash Position | 8,253 | 3,053 | 15,362 | 25,846 | 29,128 |
| Net Cash Flow | $5,200 | $-12,309 | $-10,484 | $-3,282 | $18,639 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,179 | -15,892 | -16,409 | -16,983 | -12,426 |
| Free Cash Flow | -10,179 | -15,892 | -16,409 | -16,983 | -12,426 |